Last updated: December 8, 2016
Sponsor: Ocular Therapeutix, Inc.
Overall Status: Completed
Phase
3
Condition
Eye Disease
Eye Disorders/infections
Vision Loss
Treatment
N/AClinical Study ID
NCT01498224
OTX-11-002
Ages > 22 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject has a cataract and is expected to undergo clear cornea cataract surgery withphacoemulsification and implantation of posterior chamber intraocular lens
Subject must be 22 years of age or older
Exclusion
Exclusion Criteria:
Any intraocular inflammation in study eye or presence of ocular pain in operative eyeat preoperative assessment
Previous corneal or retinal surgery or planned multiple procedures during cataractsurgery.
Study Design
Total Participants: 488
Study Start date:
December 01, 2011
Estimated Completion Date:
November 30, 2012
Connect with a study center
Levenson Eye Associates
Jacksonville, Florida 32204
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.